Table 2.
Mean ± SD data of metabolic risk factors in women and men with and without psoriasis (n = 10 521)
| Women |
Men |
|||||
|---|---|---|---|---|---|---|
| Psoriasis | No psoriasis | P-valuea | Psoriasis | No psoriasis | P-valuea | |
| Weight (kg) | 72·4 ± 13·1 | 70·9 ± 13·1 | 0·01 | 86·5 ± 13·8 | 85·6 ± 13·0 | 0·11 |
| Body mass index (kg m−2) | 27·1 ± 4·6 | 26·4 ± 4·6 | 0·002 | 27·6 ± 3·9 | 27·2 ± 3·7 | 0·03 |
| Waist circumference (cm) | 92·3 ± 12·2 | 90·4 ± 12·1 | 0·001 | 100·3 ± 11·0 | 99·2 ± 10·4 | 0·01 |
| Waist-to-hip ratio | 0·88 ± 0·07 | 0·87 ± 0·07 | < 0·001 | 0·96 ± 0·06 | 0·95 ± 0·07 | 0·003 |
| Systolic blood pressure (mmHg) | 133·1 ± 24·7 | 132·0 ± 23·8 | 0·22 | 137·5 ± 19·6 | 137·4 ± 20·2 | 0·95 |
| Diastolic blood pressure (mmHg) | 75·8 ± 10·3 | 74·7 ± 10·1 | 0·01 | 80·8 ± 10·4 | 81·3 ± 10·2 | 0·24 |
| Triglycerides (mmol L−1) | 1·54 ± 0·9 | 1·35 ± 0·7 | < 0·001 | 1·75 ± 1·0 | 1·67 ± 1·0 | 0·06 |
| Total cholesterol (mmol L−1) | 5·79 ± 1·1 | 5·66 ± 1·1 | 0·006 | 5·55 ± 1·1 | 5·52 ± 1·1 | 0·53 |
| LDL-cholesterol (mmol L−1) | 3·64 ± 1·0 | 3·52 ± 1·0 | 0·003 | 3·59 ± 0·9 | 3·57 ± 0·9 | 0·50 |
| HDL-cholesterol (mmol L−1) | 1·59 ± 0·4 | 1·66 ± 0·4 | 0·001 | 1·34 ± 0·4 | 1·36 ± 0·4 | 0·15 |
| Nonfasting glucose (mmol L−1) | 5·16 ± 1·2 | 5·08 ± 1·0 | 0·06 | 5·40 ± 1·3 | 5·38 ± 1·4 | 0·73 |
| HbA1c (%) | 5·62 ± 0·6 | 5·56 ± 0·6 | 0·006 | 5·70 ± 0·7 | 5·68 ± 0·7 | 0·56 |
| hs-CRP (mg L−1) | 3·07 ± 6·2 | 2·32 ± 4·3 | < 0·001 | 2·99 ± 4·9 | 2·37 ± 4·5 | 0·002 |
Data from the sixth Tromsø Study. Data may be from varying totals due to missing information.
a
Means were assessed by the generalized linear model, scale response for continuous variables, adjusted for age.
P-values were generated through Wald statistics. LDL, low-density lipoprotein cholesterol; HDL, high-density lipoprotein cholesterol; HbA1c, glycated haemoglobin; hs-CRP, serum high-sensitivity C-reactive protein.